Functions of yeast helicase Ssl2p that are essential for viability are also involved in protection from the toxicity of adriamycin

Nucleic Acids Research

Volumn 32, Issue 8, 2004, Pages 2578-2585

  Furuchi, Takemitsu ^a,b   Takahashi, Tsutomu ^a   Tanaka, Shogo ^a   Nitta, Katsushi ^a   Naganuma, Akira ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DOXORUBICIN; HELICASE; MUTANT PROTEIN; TRANSCRIPTION FACTOR; ANTINEOPLASTIC ANTIBIOTIC; FUNGAL PROTEIN; RAD25 PROTEIN, FUNGUS; SACCHAROMYCES CEREVISIAE PROTEIN; SSL2 PROTEIN, S CEREVISIAE;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG RESISTANCE; ENZYME ACTIVITY; EXCISION REPAIR; GENE DELETION; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; SACCHAROMYCES CEREVISIAE; YEAST CELL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; MUTATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

ANTIBIOTICS, ANTINEOPLASTIC; CYTOPROTECTION; DNA HELICASES; DOXORUBICIN; DRUG RESISTANCE; FUNGAL PROTEINS; MUTATION; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 3042671690     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh582     Document Type: Article

References (41)

1. Benjamin,R.S., Wiernik,P.H. and Bachur,N.R. (1974) Adriamycin chemotherapy - efficacy, safety and pharmacologic basis of an intermittent single high-dosage schedule. Cancer, 33, 19-27.
2. Gewirtz,D.A. (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol., 57, 727-741.
3. Ueda,K., Clark,D.P., Chen,C.J., Roninson,I.B., Gottesman,M.M. and Pastan,I. (1987) The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J. Biol. Chem., 262, 505-508.
4. Lincke,C.R., van der Bliek,A.M., Schuurhuis,G.J., van der Velde-Koerts,T., Smit,J.J. and Borst,P. (1990) Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Cancer Res., 50, 1779-1785.
5. Cole,S.P., Bhardwaj,G., Gerlach,J.H., Mackie,J.E., Grant,C.E., Almquist,K.C., Stewart,A.J., Kurz,E.U., Duncan,A.M. and Deeley,R.G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
6. Grant,C.E., Valdimarsson,G.,Hipfner,D.R., Almquist,K.C., Cole,S.P. and Deeley,R.G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54, 357-361.
7. Longhurst,T.J., O'Neill,G.M., Harvie,R.M. and Davey,R.A. (1996) The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. Br. J. Cancer, 74, 1331-1335.
8. O'Neill,G.M., Peters,G.B., Harvie,R.M., MacKenzie,H.B., Henness,S. and Davey,R.A. (1998) Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines. Br. J. Cancer, 77, 2076-2080.
9. Doyle,L.A., Yang,W., Abruzzo,L.V., Krogmann,T., Gao,Y., Rishi,A.K. and Ross,D.D. (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl Acad. Sci. USA, 95, 15665-15670.
10. Allen,J.D., Brinkhuis,R.F., Wijnholds,J. and Schinkel,A.H. (1999) The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res., 59, 4237-4241.
11. Scheper,R.J., Broxterman,H.J., Scheffer,G.L., Kaaijk,P., Dalton,W.S., van Heijningen,T.H., van Kalken,C.K., Slovak,M.L., de Vries,E.G. and van der Valk,P. (1993) Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53, 1475-1479.
12. Slovak,M.L., Ho,J.P., Cole,S.P., Deeley,R.G., Greenberger,L., de Vries,E.G., Broxterman,H.J., Scheffer,G.L. and Scheper,R.J. (1995) The LRP gene encoding a major vault protein associated with drug resistance maps proximal to MRP on chromosome 16: evidence that chromosome breakage plays a key role in MRP or LRP gene amplification. Cancer Res., 55, 4214-4219.
13. Withoff,S., De Jong,S., De Vries,E.G. and Mulder,N.H. (1996) Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review). Anticancer Res., 16, 1867-1880.
14. Zwelling,L.A., Hinds,M., Chan,D., Mayes,J., Sie,K.L., Parker,E., Silberman,L., Radcliffe,A., Beran,M. and Blick,M. (1989) Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J. Biol. Chem., 264, 16411-16420.
15. Singh,S.V., Nair,S., Ahmad,H., Awasthi,Y.C. and Krishan,A. (1989) Glutathione S-transferases and glutathione peroxidases in doxorubicin-resistant murine leukemic P388 cells. Biochem. Pharmacol., 38, 3505-3510.
16. Kolaczkowski,M., van der Rest,M., Cybularz-Kolaczkowska,A., Soumillion,J.P., Konings,W.N. and Goffeau,A. (1996) Anticancer drugs, ionophoric peptides and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem., 271, 31543-31548.
17. Kule,C., Ondrejickova,O. and Verner,K. (1994) Doxorubicin, daunorubicin and mitoxantrone cytotoxicity in yeast. Mol. Pharmacol., 46, 1234-1240.
18. Park,E., Guzder,S.N., Koken,M.H., Jaspers-Dekker,I., Weeda,G., Hoeijmakers,J.H., Prakash,S. and Prakash,L. (1992) RAD25 (SSL2), the yeast homolog of the human xeroderma pigmentosum group B DNA repair gene, is essential for viability. Proc. Natl Acad. Sci. USA, 89, 11416-11420.
19. Qiu,H., Park,E., Prakash,L. and Prakash,S. (1993) The Saccharomyces cerevisiae DNA repair gene RAD25 is required for transcription by RNA polymerase II. Genes Dev., 7, 2161-2171.
20. Wang,Z., Svejstrup,J.Q., Feaver,W.J., Wu,X., Kornberg,R.D. and Friedberg,E.C. (1994) Transcription factor b (TFIIH) is required during nucleotide-excision repair in yeast. Nature, 368, 74-76.
21. Furuchi,T., Ishikawa,H., Miura,N., Ishizuka,M., Kajiya,K., Kuge,S. and Naganuma,A. (2001) Two nuclear proteins, Cin5 and Ydr259c, confer resistance to cisplatin in Saccharomyces cerevisiae. Mol. Pharmacol., 59, 470-474.
22. Furuchi,T., Hwang,G.W. and Naganuma,A. (2002) Overexpression of the ubiquitin-conjugating enzyme Cdc34 confers resistance to methylmercury in Saccharomyces cerevisiae. Mol. Pharmacol., 61, 738-741.
23. Miura,N., Kaneko,S., Hosoya,S., Furuchi,T., Miura,K., Kuge,S. and Naganuma,A. (1999) Overexpression of L-glutamine:D-fructose-6-phosphate amidotransferase provides resistance to methylmercury in Saccharomyces cerevisiae. FEBS Lett., 458, 215-218.
24. Gonzalez,C., Perdomo,G., Tejera,P., Brito,N. and Siverio,J.M. (1999) One-step, PCR-mediated, gene disruption in the yeast Hansenula polymorpha. Yeast, 15, 1323-1329.
25. Hwang,G.W., Furuchi,T. and Naganuma,A. (2002) A ubiquitin-proteasome system is responsible for the protection of yeast and human cells against methylmercury. FASEB J., 16, 709-711.
26. Sherman,F. and Hicks,J. (1991) Micromanipulation and dissection of asci. Methods Enzymol., 194, 21-37.
27. Roy,R., Schaeffer,L., Humbert,S., Vermeulen,W., Weeda,G. and Egly,J.M. (1994) The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2/TFIIH. J. Biol. Chem., 269, 9826-9832.
28. Furuchi,T., Nitta,K., Takahashi,T. and Naganuma,A. (2004) Overexpression of Ssl2p confers resistance to adriamycin and actinomycin D in Saccharomyces cerevisiae. Biochem. Biophys. Res. Commun., 314, 844-848.
29. vanBrabant,A.J., Stan,R. and Ellis,N.A. (2000) DNA helicases, genomic instability and human genetic disease. Annu. Rev. Genomics Hum. Genet., 1, 409-459.
30. Berneburg,M. and Lehmann,A.R. (2001) Xeroderma pigmentosum and related disorders: defects in DNA repair and transcription. Adv. Genet., 43, 71-102.
31. Sweder,K.S. and Hanawalt,P.C. (1994) The COOH terminus of suppressor of stem loop (SSL2/RAD25) in yeast is essential for overall genomic excision repair and transcription-coupled repair. J. Biol. Chem., 269, 1852-1857.
32. Yang,W.L., Cvijic,M.E., Ishii,K. and Chin,K.V. (1998) The requirement of yeast Ssl2 (Rad25) for the repair of cisplatin-damaged DNA. Biochem. Biophys. Res. Commun., 250, 593-597.
33. Damia,G., Guidi,G. and D'Incalci,M. (1998) Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur. J. Cancer, 34, 1783-1788.
34. Bachur,N.R., Yu,F., Johnson,R., Hickey,R., Wu,Y. and Malkas,L. (1992) Helicase inhibition by anthracycline anticancer agents. Mol. Pharmacol., 41, 993-998.
35. Bachur,N.R., Lun,L., Sun,P.M., Trubey,C.M., Elliott,E.E., Egorin,M.J., Malkas,L. and Hickey,R. (1998) Anthracycline antibiotic blockade of SV40 T antigen helicase action. Biochem. Pharmacol., 55, 1025-1034.
36. Enomoto,T. (2001) Functions of RecQ family helicases: possible involvement of Bloom's and Werner's syndrome gene products in guarding genome integrity during DNA replication. J. Biochem. (Tokyo), 129, 501-507.
37. Onoda,F., Seki,M., Miyajima,A. and Enomoto,T. (2001) Involvement of SGS1 in DNA damage-induced heteroallelic recombination that requires RAD52 in Saccharomyces cerevisiae. Mol. Gen. Genet., 264, 702-708.
38. Prakash,S. and Prakash,L. (2000) Nucleotide excision repair in yeast. Mutat. Res., 451, 13-24.
39. Ma,L., Westbroek,A., Jochemsen,A.G., Weeda,G., Bosch,A., Bootsma,D., Hoeijmakers,J.H. and van der Eb,A.J. (1994) Mutational analysis of ERCO, which is involved in DNA repair and transcription initiation: identification of domains essential for the DNA repair function. Mol. Cell. Biol., 14, 4126-4134.
40. Boeke,J.D., Trueheart,J., Natsoulis,G. and Fink,G.R. (1987) 5-Fluoroorotic acid as a selective agent in yeast molecular genetics. Methods Enzymol., 154, 164-175.
41. Lee,B.S., Lichtenstein,C.P., Faiola,B., Rinckel,L.A., Wysock,W., Curcio,M.J. and Garfinkel,D.J. (1998) Posttranslational inhibition of Ty1 retrotransposition by nucleotide excision repair/transcription factor TFIIH subunits Ssl2p and Rad3p. Genetics, 148, 1743-1761.